Abstract
The CCAAT/enhancer binding protein (C/EBP) family of bZIP transcription factors control the proliferation and differentiation of a variety of tissues. While C/EBPα and -∂ are also expressed in the mammary gland, the multiple protein isoforms of C/EBPβ appear to play a critical role in mammary gland development and breast cancer. Targeted deletion of all the C/EBPβ isoforms results in a severe inhibition of lobuloalveolar development and a block to functional differentiation, as well as more subtle changes in ductal morphogenesis. The altered expression of a number of molecular markers, including the progesterone, estrogen, and prolactin receptors, the transporter proteins (NKCC1 and aquaporin 5), and several markers of skin differentiation (Sprr2A and keratin 6), suggests that germline deletion of C/EBPβ results in an altered cell fate. Thus, C/EBPβ appears to play a role in the specification of progenitor cell fate not only in the mammary gland, but also in a number of other tissues.
Similar content being viewed by others
REFERENCES
D. P. Ramji and P. Foka (2002). CCAAT/enhancer-binding proteins: Structure, function and regulation. Biochem J. 365:561–575.
Z. Cao, R. M. Umek, and S. L. McKnight (1991). Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5:1538–1552.
M. Takiguchi (1998). The C/EBP family of transcription factors in the liver and other organs. Int. J. Exp. Pathol. 79:369–391.
S. Osada, H. Yamamoto, T. Nishihara, and M. Imagawa (1996). DNAbinding specificity of the CCAAT/enhancer-binding protein transcription factor family. J. Biol. Chem. 271:3891–3896.
W. C. Yeh, Z. Cao, M. Classon, and S. L. McKnight (1995). Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9:168–181.
K. P. LeClair, M. A. Blanar, P. A. Sharp (1992). The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor. Proc. Natl. Acad. Sci. U. S. A. 89:8145–8149.
Y. Nishio, H. Isshiki, T. Kishimoto, and S. Akira (1993). A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction. Mol. Cell. Biol. 13:1854–1862.
M. Christian, Y. Pohnke, R. Kempf, B. Gellersen, and J. J. Brosens (2002). Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: Promoterdependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. Mol. Endocrinol. 16:141–154.
S. Mink, B. Haenig, and K. H. Klempnauer (1997). Interaction and functional collaboration of p300 and C/EBPbeta. Mol. Cell. Biol. 17:6609–6617.
P. L. Chen, D. J. Riley, S. Chen-Kiang, and W. H. Lee (1996). Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc. Natl. Acad. Sci. U. S. A. 93:465–469.
C. A. Zahnow (2002). CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res. 4:113–121.
S. L. McKnight (2001). McBindall-A better name for CCAAT/enhancer binding proteins? Cell 107:259–261.
W. J. Roesler (2001). The role of C/EBP in nutrient and hormonal regulation of gene expression. Annu. Rev. Nutr. 21:141–165.
R. Yamanaka, J. Lekstrom-Himes, C. Barlow, A. Wynshaw-Boris, and K. G. Xanthopoulos (1998). CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis [Review]. Int. J. Mol. Med. 1:213–221.
J. Lekstrom-Himes and K. G. Xanthopoulos (1998). Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273:28545–28548.
N. A. Jenkins, D. J. Gilbert, B. C. Cho, M. C. Strobel, S. C. Williams, N. G. Copeland, et al. (1995). Mouse chromosomal location of the CCAAT/enhancer binding proteins C/EBP beta (Cebpb), C/EBP delta (Cebpd), and CRP1 (Cebpe). Genomics 28:333–336.
L. R. Hendricks-Taylor, L. L. Bachinski, M. J. Siciliano, A. Fertitta, B. Trask, P. J. de Jong, et al. (1992). The CCAAT/enhancer binding protein (C/EBP alpha) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP beta) gene (CEBPB) maps to human chromosome 20q13.1. Genomics 14:12–17.
Y. Yang, E. I. Pares-Matos, V. M. Tesmer, C. Dai, S. Ashworth, J. Huai, et al. (2002). Organization of the promoter region of the human NF-IL6 gene. Biochim. Biophys. Acta 1577:102–108.
C. J. Chang, B. J. Shen, and S. C. Lee (1995). Autoregulated induction of the acute-phase response transcription factor gene, agp/ebp. DNA Cell Biol. 14:529–537.
W. C. Lin, B. J. Shen, Y. G. Tsay, H. C. Yen, S. C. Lee, and C. J. Chang (2002). Transcriptional activation of C/EBPbeta gene by c-Jun and ATF2. DNA Cell Biol. 21:551–560.
M. Niehof, S. Kubicka, L. Zender, M. P. Manns, and C. Trautwein (2001). Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcription. J. Mol. Biol. 309:855–868.
S. Mink, S. Jaswal, O. Burk, and K. H. Klempnauer (1999). The v-Myb oncoprotein activates C/EBPbeta expression by stimulating an autoregulatory loop at the C/EBPbeta promoter. Biochim. Biophys. Acta 1447:175–184.
P. Foka, S. Kousteni, and D. P. Ramji (2001). Molecular characterization of the Xenopus CCAAT-enhancer binding protein beta gene promoter. Biochem. Biophys. Res. Commun. 285:430–436.
M. Niehof, M. P. Manns, and C. Trautwein (1997). CREB controls LAP/C/EBP beta transcription. Mol. Cell Biol. 17:3600–3613.
M. Niehof, K. Streetz, T. Rakemann, S. C. Bischoff, M. P. Manns, F. Horn, et al. (2001). Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3. J. Biol. Chem. 276:9016–9027.
A. Berrier, G. Siu, and K. Calame (1998). Transcription of a minimal promoter from the NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promonocytic cells. J. Immunol. 161:2267–2275.
P. Descombes and U. Schibler (1991). A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569–579.
V. Ossipow, P. Descombes, and U. Schibler (1993). CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. U. S. A. 90:8219–8223.
L. T. Timchenko, P. Iakova, A. L. Welm, Z. J. Cai, and N. A. Timchenko (2002). Calreticulin interacts with C/EBPalpha and C/EBPbeta mRNAs and represses translation of C/EBP proteins. Mol. Cell Biol. 22:7242–7257.
C. F. Calkhoven, C. Muller, and A. Leutz (2000). Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev. 14:1920–1932.
E. Kowenz-Leutz, G. Twamley, S. Ansieau, and A. Leutz (1994). Novel mechanism of C/EBP beta (NF-M) transcriptional control: Activation through derepression. Genes Dev. 8:2781–2791.
S. C. Williams, M. Baer, A. J. Dillner, and P. F. Johnson (1995). CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. Embo. J. 14:3170–3183.
E. Kowenz-Leutz and A. Leutz (1999). A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol. Cell 4:735–743.
A. L. Welm, N. A. Timchenko, and G. J. Darlington (1999). C/EBPalpha regulates generation of C/EBPbeta isoforms through activation of specific proteolytic cleavage. Mol. Cell. Biol. 19:1695–1704.
M. Baer and P. F. Johnson (2000). Generation of truncated C/EBPbeta isoforms by in vitro proteolysis. J. Biol. Chem. 275:26582–26590.
G. W. Robinson, P. F. Johnson, L. Hennighausen, and E. Sterneck (1998). The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev. 12:1907–1916.
A. P. Gigliotti and J. W. DeWille (1998). Lactation status influences expression of CCAAT/enhancer binding protein isoform mRNAin the mouse mammary gland. J. Cell. Physiol. 174:232–239.
G. Sabatakos, G. E. Davies, M. Grosse, A. Cryer, and D. P. Ramji (1998). Expression of the genes encoding CCAAT-enhancer binding protein isoforms in the mouse mammary gland during lactation and involution. Biochem. J. 334(Pt. 1):205–210.
T. N. Seagroves, S. Krnacik, B. Raught, J. Gay, B. Burgess-Beusse, G. J. Darlington, et al. (1998). C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev. 12:1917–1928.
B. Raught, W. S. Liao, and J. M. Rosen (1995). Developmentally and hormonally regulatedCCAAT/enhancer-binding protein isoforms influence beta-casein gene expression. Mol. Endocrinol. 9:1223–1232.
L. R. Dearth, J. Hutt, A. Sattler, A. Gigliotti, and J. DeWille (2001). Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammarygland, tumors and culturedmammaryepithelial cells. J. Cell. Biochem. 82:357–370.
J. M. Rosen, C. Zahnow, A. Kazansky, and B. Raught (1998). Composite response elements mediate hormonal and developmental regulation of milk protein gene expression. Biochem. Soc. Symp. 63:101–113.
J. M. Rosen, S. L. Wyszomierski, and D. Hadsell (1999). Regulation of milk protein gene expression. Annu. Rev. Nutr. 19:407–436.
C. A. Zahnow, R. D. Cardiff, R. Laucirica, D. Medina, and J. M. Rosen (2001). A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res. 61:261–269.
S. L. Wyszomierski and J. M. Rosen (2001). Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol. Endocrinol. 15:228–240.
I. Screpanti, L. Romani, P. Musiani, A. Modesti, E. Fattori, D. Lazzaro, et al. (1995). Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. Embo. J. 14:1932–1941.
T. Tanaka, S. Akira, K. Yoshida, M. Umemoto, Y. Yoneda, N. Shirafuji, et al. (1995). Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353–361.
G. J. Darlington, S. E. Ross, and O. A. MacDougald (1998). The role of C/EBP genes in adipocyte differentiation. J. Biol. Chem. 273:30057–30060.
T. Tanaka, N. Yoshida, T. Kishimoto, and S. Akira (1997). Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. Embo. J. 16:7432–7443.
C. Croniger, M. Trus, K. Lysek-Stupp, H. Cohen, Y. Liu, G. J. Darlington, et al. (1997). Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth. J. Biol. Chem. 272:26306–26312.
L. E. Greenbaum, W. Li, D. E. Cressman, Y. Peng, G. Ciliberto, V. Poli, et al. (1998). CCAAT enhancer-binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J. Clin. Invest. 102:996–1007.
E. V. Maytin and J. F. Habener (1998). Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J. Invest. Dermatol. 110:238–246.
E. V. Maytin, J. C. Lin, R. Krishnamurthy, N. Batchvarova, D. Ron, P. J. Mitchell, et al. (1999). Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2. Dev. Biol. 216:164–181.
E. Sterneck, L. Tessarollo, and P. F. Johnson (1997). An essential role for C/EBPbeta in female reproduction. Genes Dev. 11:2153–2162.
N. D. Wang, M. J. Finegold, A. Bradley, C. N. Ou, S. V. Abdelsayed, M. D. Wilde, et al. (1995). Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269:1108–1112.
A. P. Gigliotti, P. F. Johnson, E. Sterneck, and J. W. DeWille (2003). Nulliparous CCAAT/enhancer binding proteindelta (C/EBPdelta) knockout mice exhibit mammary gland ductal hyperlasia. Exp. Biol. Med. (Maywood) 228:278–285.
L. Hennighausen and G. W. Robinson (2001). Signaling pathways in mammary gland development. Dev. Cell 1:467–475.
J. M. Shillingford and L. Hennighausen (2001). Experimental mouse genetics-Answering fundamental questions about mammary gland biology. Trends Endocrinol. Metab. 12:402–408.
T. N. Seagroves, J. P. Lydon, R. C. Hovey, B. K. Vonderhaar, and J. M. Rosen (2000). C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol. Endocrinol. 14:359–368.
O. M. Conneely and B. M. Jericevic (2002). Progesterone regulation of reproductive function through functionally distinct progesterone receptor isoforms. Rev. Endocr. Metab. Disord. 3:201–209.
G. B. Silberstein, K. Van Horn, G. Shyamala, C. W. Daniel (1996). Progesterone receptors in the mouse mammary duct: Distribution and developmental regulation. Cell Growth Differ. 7:945–952.
S. L. Grimm, T. N. Seagroves, E. B. Kabotyanski, R. C. Hovey, B. K. Vonderhaar, J. P. Lydon, et al. (2002). Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol. Endocrinol. 16:2675–2691.
P. Kopf-Maier and V. F. Mboneko (1990). Anomalies in the hormonal status of athymic nude mice. J. Cancer Res. Clin. Oncol. 116:229–231.
R. B. Clarke, A. Howell, C. S. Potten, and E. Anderson (1997). Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57:4987–4991.
J. Russo, X. Ao, C. Grill, and I. H. Russo (1999). Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res. Treat. 53:217–227.
R. C. Hovey, J. F. Trott, E. Ginsburg, A. Goldhar, M. M. Sasaki, S. J. Fountain, et al. (2001). Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev. Dyn. 222:192–205.
E. Delpire and D. B. Mount (2002). Human and murine phenotypes associated with defects in cation-chloride cotransport. Annu. Rev. Physiol. 64:803–843.
J. M. Shillingford, K. Miyoshi, M. Flagella, G. E. Shull, and L. Hennighausen (2002). Mouse mammary epithelial cells express the Na-K-Cl cotransporter, NKCC1: Characterization, localization, and involvement in ductal development and morphogenesis. Mol. Endocrinol. 16:1309–1321.
A. S. Verkman and A. K. Mitra (2000). Structure and function of aquaporin water channels. Am. J. Physiol. Renal. Physiol. 278:F13-F28.
J. M. Shillingford, K. Miyoshi, G. W. Robinson, B. Bierie, Y. Cao, M. Karin, et al. (2003). Proteotyping of mammary tissue from transgenic and gene knockout mice with immunohistochemical markers: A tool to define developmental lesions. J. Histochem. Cytochem. 51:555–565.
J. M. Veltmaat, A. A. Mailleux, J. P. Thiery, and S. Bellusci (2003). Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation 71:1–17.
G. H. Smith, T. Mehrel, and D. R. Roop (1990). Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium. Cell Growth Differ. 1:161–170.
A. Sapino, L. Macri, P. Gugliotta, D. Pacchioni, Y. J. Liu, D. Medina, et al. (1993). Immunophenotypic properties and estrogen dependency of budding cell structures in the developing mouse mammary gland. Differentiation 55:13–18.
V. Vegesna, S. Takeuchi, W. K. Hofmann, T. Ikezoe, S. Tavor, U. Krug, et al. (2002). C/EBP-beta, C/EBP-delta, PU.1, AML1 genes: Mutational analysis in 381 samples of hematopoietic and solid malignancies. Leuk. Res. 26:451–457.
T. Pabst, B. U. Mueller, P. Zhang, H. S. Radomska, S. Narravula, S. Schnittger, et al. (2001). Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat. Genet. 27:263–270.
B. Raught, A. C. Gingras, A. James, D. Medina, N. Sonenberg, and J. M. Rosen (1996). Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells. Cancer Res. 56:4382–4386.
C. A. Zahnow, P. Younes, R. Laucirica, and J. M. Rosen (1997). Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J. Natl. Cancer. Inst. 89:1887–1891.
K. Sundfeldt, K. Ivarsson, M. Carlsson, S. Enerback, P. O. Janson, M. Brannstrom, et al. (1999). The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: Specific increase in C/EBPbeta during epithelial tumour progression. Br. J. Cancer 79:1240–1248.
K. Rask, M. Thorn, F. Ponten, W. Kraaz, K. Sundfeldt, L. Hedin, et al. (2000). Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBPbeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer. Int. J. Cancer 86:337–343.
S. Zhu, K. Yoon, E. Sterneck, P. F. Johnson, and R. C. Smart (2002). CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc. Natl. Acad. Sci. U. S. A. 99:207–212.
E. M. Eaton, M. Hanlon, L. Bundy, and L. Sealy (2001). Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells. J. Cell. Physiol. 189:91–105.
L. M. Bundy and L. Sealy (2003). CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22:869–883.
M. Cortes-Canteli, M. Pignatelli, A. Santos, and A. Perez-Castillo (2002). CCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cells. J. Biol. Chem. 277:5460–5467.
A. M. Diehl (1998). Roles of CCAAT/enhancer-binding proteins in regulation of liver regenerative growth. J. Biol. Chem. 273:30843–30846.
S. Zhu, H. S. Oh, M. Shim, E. Sterneck, P. F. Johnson, R. C. Smart (1999). C/EBPbeta modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Mol. Cell Biol. 19:7181–7190.
J. M. Shillingford, K. Miyoshi, G. W. Robinson, S. L. Grimm, J. M. Rosen, H. Neubauer, et al. (2002). Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium. Mol. Endocrinol. 16:563–570.
M. Xu, L. Nie, S. H. Kim, and X. H. Sun (2003). STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta. EMBO J. 22:893–904.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grimm, S.L., Rosen, J.M. The Role of C/EBPβ in Mammary Gland Development and Breast Cancer. J Mammary Gland Biol Neoplasia 8, 191–204 (2003). https://doi.org/10.1023/A:1025900908026
Issue Date:
DOI: https://doi.org/10.1023/A:1025900908026